Albiruni Abdul Razak Selected Research

Vomiting

1/2023

Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albiruni Abdul Razak Research Topics

Disease

3	Neoplasms (Cancer) 01/2020 - 01/2019
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2024 - 12/2022
2	Nausea 01/2023 - 01/2022
2	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2022
1	Disease Progression 01/2024
1	Constipation 10/2023
1	Hand-Foot Syndrome 01/2023
1	Chondrosarcoma 01/2023
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	Vomiting 01/2023
1	Mucositis 01/2023
1	Rhabdomyosarcoma 11/2022
1	Liposarcoma 01/2022
1	Fatigue 01/2022

Drug/Important Bio-Agent (IBA)

3	Sunitinib (Sutent)FDA Link 01/2024 - 12/2022
3	ripretinibIBA 01/2024 - 12/2022
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2020
2	Imatinib Mesylate (Gleevec)FDA Link 01/2024 - 12/2022
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2022
2	pembrolizumabIBA 01/2020 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
1	cabozantinibIBA 01/2023
1	regorafenibIBA 01/2023
1	BilirubinIBA 01/2023
1	selinexorIBA 01/2022
1	Circulating Tumor DNAIBA 01/2020

Therapy/Procedure

1	Drug Tapering 01/2023
1	Aftercare (After-Treatment) 12/2022
1	Radiotherapy 11/2022
1	Immunotherapy 01/2019